Daniel Carpenter
Daniel Carpenter
Allie S. Freed Professor of Government, Harvard University
Zweryfikowany adres z gov.harvard.edu
Cytowane przez
Cytowane przez
The forging of bureaucratic autonomy: Reputations, networks, and policy innovation in executive agencies, 1862-1928
D Carpenter
Princeton University Press, 2002
Reputation and power: organizational image and pharmaceutical regulation at the FDA
D Carpenter
Princeton University Press, 2014
Preventing regulatory capture: Special interest influence and how to limit it
D Carpenter, DA Moss
Cambridge University Press, 2013
Reputation and public administration
DP Carpenter, GA Krause
Public administration review 72 (1), 26-32, 2012
Global health security: the wider lessons from the west African Ebola virus disease epidemic
DL Heymann, L Chen, K Takemi, DP Fidler, JW Tappero, MJ Thomas, ...
The Lancet 385 (9980), 1884-1901, 2015
The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect
P Cram, AM Fendrick, J Inadomi, ME Cowen, D Carpenter, S Vijan
Archives of Internal Medicine 163 (13), 1601-1605, 2003
A formal model of learning and policy diffusion
C Volden, MM Ting, DP Carpenter
American Political Science Review 102 (3), 319-332, 2008
Groups, the media, agency waiting costs, and FDA drug approval
DP Carpenter
American Journal of Political Science, 490-505, 2002
Failure of investigational drugs in late-stage clinical development and publication of trial results
TJ Hwang, D Carpenter, JC Lauffenburger, B Wang, JM Franklin, ...
JAMA internal medicine 176 (12), 1826-1833, 2016
Protection without capture: Product approval by a politically responsive, learning regulator
DP Carpenter
American Political Science Review 98 (4), 613-631, 2004
Adaptive signal processing, hierarchy, and budgetary control in federal regulation
DP Carpenter
American Political Science Review 90 (2), 283-302, 1996
Friends, brokers, and transitivity: Who informs whom in Washington politics?
DP Carpenter, KM Esterling, DMJ Lazer
The journal of Politics 66 (1), 224-246, 2004
Drug-review deadlines and safety problems
D Carpenter, EJ Zucker, J Avorn
New England Journal of Medicine 358 (13), 1354-1361, 2008
The political economy of FDA drug review: processing, politics, and lessons for policy
DP Carpenter
Health affairs 23 (1), 52-63, 2004
The strength of weak ties in lobbying networks: Evidence from health-care politics in the United States
DP Carpenter, KM Esterling, DMJ Lazer
Journal of Theoretical Politics 10 (4), 417-444, 1998
Are close elections random?
J Grimmer, E Hersh, B Feinstein, D Carpenter
Unpublished manuscript, 1-38, 2011
The strength of strong ties: A model of contact-making in policy networks with evidence from US health politics
D Carpenter, K Esterling, D Lazer
Rationality and Society 15 (4), 411-440, 2003
Transactional authority and bureaucratic politics
D Carpenter, GA Krause
Journal of Public Administration Research and Theory 25 (1), 5-25, 2015
Political learning from rare events: Poisson inference, fiscal constraints, and the lifetime of bureaus
DP Carpenter, DE Lewis
Political Analysis 12 (3), 201-232, 2004
Is health politics different?
D Carpenter
Annual Review of Political Science 15, 287-311, 2012
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20